General methods
General reagents and solvents were commercially available and used as received. [Ru(pcymene)Cl 2 (pta)] (pta = 1,3,5-triaza-7-phospaadamantane), termed RAPTA-C, was synthesized according to the literature method proposed by C. S. Allardyce et al. Chem. Commun., 2001, 1396. 1 H and 13 C NMR were acquired on a 500 MHz Varian Equipment using CDCl 3 as solvent. Thermogravimetric and differential calorimetric analyses were performed, under air atmosphere, on a Shimadzu-TGA-50H/DSC equipment, at a heating rate of 20 ºC min -1 . UV-vis spectra were collected on a Thermo Unicam UV 300.
Except for the structural analysis, XRPD data were collected on a Bruker D2-PHASER diffractometer using CuK radiation ( = 1.5418 Å). The compounds were manually grounded in an agate mortar, then deposited in the hollow of a silicon sample holder. N 2 adsorption isotherms were measured at 77 K on a Micromeritics Tristar 3000 volumetric instrument. Prior to measurement, powdered samples were activated by heating at 130 ºC for 7 h and outgassing to 10 41 mmol) were stirred in a deoxygenated mixture of Et 3 N (8 mL) and dry THF (10 mL) under an Ar atmosphere for 5 min at room temperature. Subsequently, trimethylsilylacethylene (0.33 g, 3.40 mmol) was slowly added and the mixture was stirred for 3 h. The solvent was removed and the residue was dissolved in ethylacetate (15 mL) and washed with a saturated solution of ammonium chloride (5 mL × 3). The organic phase was dried over anhydrous Na 2 SO 4 and the solvent was removed. The residue was purified by column chromatography (silica gel, hexane/EtOAc 9:1) to yield 0.84 g (94%) of 2 as oil. Preparation of 1,1'-di-Boc-4,4'-(buta-1,3-diyne-1,4-diyl)bispyrazole (4): Terminal alkyne 3 (0.6 g, 3.14 mmol), dichloro-bis(triphenylphosphine) palladium(II) (0.22 g, 0.31 mmol) and copper(I) iodide (0.07 g, 0.38 mmol) were stirred for 4 h at room temperature in a mixture of Et 3 N (8 mL) and dioxane (20 mL). Subsequently, the solvent was removed and the residue was dissolved in EtOAc (20 mL). The resulting solution was washed with a saturated aqueous solution of ammonium chloride (5 mL × 3). Afterwards, the organic phase was dried over anhydrous Na 2 SO 4 and the solvent was removed. The resulting residue was purified by column chromatography (silica gel, hexane/EtOAc 8:2) to yield 0.37 g (62%) of 4 as white needles. IR (KBr) (cm The as synthesized solid, 1·H 2 O·DMF, was suspended in CH 2 Cl 2 for 4 h to exchange the host solvent molecules in order to decrease the activation/evacuation temperature. 
Chemical stability tests on 1
Each test has been performed suspending 20 mg of activated 1 into 10 mL of the desired solvent for 24h. Afterwards, the solid was filtered off and dried 1h in air at room temperature before XRPD acquisition.
It should be highlighted that the bulk solid is stable in acid conditions (HCl 0.01M, pH 2.3, 24h, rt) as its XRPD is not affected after this treatment and its crystallinity is maintained. However, it should be pointed out that the quantity of recovered solid after the treatment seems to be diminished suggesting that the MOF is progressively leached under these conditions. ) to 100 mg of the original sample during 60 seconds. In order to register the XRP diffractograms and to measure the N 2 adsorption at 77 K, the pellets were gently grounded in an agate mortar. mbar. Under these conditions, the complete removal of the guest molecules in order to obtain empty pores ready for RAPTA-C adsorption could be achieved.
Measurement of the adsorption isotherm of RAPTA-C at 298 K: RAPTA-C solutions were prepared using increasing concentrations of RAPTA-C by dissolving 5, 
Release of RAPTA-C:
The delivery of RAPTA-C in simulated body fluid (SBF) at 323 K has been studied. SBF was prepared according to literature methods. 2 With this purpose, we prepare two solutions, A and B (Table S1 ), that must be mixed just before each experiment in order to avoid the possible precipitation of some low soluble inorganic salts. 
X-ray powder diffraction of 1 and 1·RAPTA-C
The loaded form 1·RAPTA-C has been obtained suspending 10 mg of activated 1 into 20 mL of an aqueous RAPTA-C solution (0.025 M), stirring at 25º C for 4 hours to ensure that the equilibrium is reached. The solid was filtered, washed quickly with 1 mL of distilled water and dried under reduced pressure. 9. Pore size distribution on 1. Figure S6 . Pore size distribution was calculated using the BJH method. As it can be observed the pore size is in the microporous range (pore size  1.5 nm). 
